Sun Pharmaceutical Industries’ arm gets nod to set up greenfield project

03 Dec 2025 Evaluate

Sun Pharmaceutical Industries’ wholly-owned subsidiary – Sun Pharma Laboratories has received approval from Board of Directors for an investment of Rs 3,000 crore for setting up a greenfield formulations manufacturing facility in Madhya Pradesh.

Earlier, the company had launched its global innovative drug, ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1805.00 -13.60 (-0.75%)
05-Dec-2025 12:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1279.30
Cipla 1522.50
Zydus Lifesciences 933.85
Lupin 2099.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×